91475-01-3

Basic information

• Product Name: methyl N-boc-D-ala-L-ala-O,N-dimethyl-L-tyr-L-alaninate
• Synonyms: methyl N-boc-D-ala-L-ala-O,N-dimethyl-L-tyr-L-alaninate
• CAS NO: 91475-01-3
• Molecular Weight: 536.626
• Mol File: 91475-01-3.mol

Chemical Properties

• CAS DataBase Reference: methyl N-boc-D-ala-L-ala-O,N-dimethyl-L-tyr-L-alaninate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl N-boc-D-ala-L-ala-O,N-dimethyl-L-tyr-L-alaninate(91475-01-3)
• EPA Substance Registry System: methyl N-boc-D-ala-L-ala-O,N-dimethyl-L-tyr-L-alaninate(91475-01-3)

Safety Data

• Hazardous Substances Data: 91475-01-3(Hazardous Substances Data)

Upstream product

• 3744-87-4 Boc-(R)-Ala 
• 69340-16-5 methyl L-ala-O,N-dimethyl-L-tyr-L-alaninate 
• 91474-98-5 methyl O,N-dimethyl-L-tyr-L-alaninate 
• 112196-49-3 (S)-2-((R)-2-tert-butoxycarbonylamino-1-hydroxy-propylamino)-propionic acid 
• 73584-84-6 (S)-2-(tert-butoxycarbonyl(methyl)amino)-3-(4-methoxyphenyl)propanoic acid 
• 135103-27-4 C₁₆H₂₃NO₅*C₁₂H₂₃N 
• 71257-76-6 Boc-D-Ala-Ala-OMe 
• 91475-00-2 methyl N-boc-L-ala-O,N-dimethyl-L-tyr-L-alaninate 
• 91474-97-4 methyl O,N-dimethyl-N-boc-L-tyr-L-alaninate 

Downstream Products

• 112196-84-6 BOC-D-Ala-L-Ala-NMe-L-Tyr(OMe)-L-Ala-OH 
• 91474-95-2 methyl D-ala-L-ala-O,N-dimethyl-L-tyr-L-alaninate 
• 91502-34-0 cyclo-N-methyl-L-tyr-N-methyl-L-tyr-D-ala-L-ala-O,N-dimethyl-L-tyr-L-ala 
• 91502-35-1 methyl N-methyl-L-tyr-N-methyl-L-tyr-D-ala-L-ala-O,N-dimethyl-L-tyr-L-alaninate 
• 91475-02-4 methyl N-boc-N-methyl-L-tyr-N-methyl-L-tyr-D-ala-L-ala-O,N-dimethyl-L-tyr-L-alaninate 
• 112219-54-2 3-(3-{4-[2-({(S)-2-[(S)-2-{[(S)-2-((R)-2-Amino-propionylamino)-propionyl]-methyl-amino}-3-(4-methoxy-phenyl)-propionylamino]-propionyl}-methyl-amino)-ethyl]-phenoxy}-phenyl)-propionic acid pentafluorophenyl ester; compound with trifluoro-acetic acid 
• 112196-67-5 C₄₆H₅₁F₅N₆O₁₀*C₂HF₃O₂ 
• 112196-48-2 cyclo-(D-Ala-Ala-N-Me-Tyr(OMe)-Ala) 
• 112196-46-0 Cyclo-(D-Ala-Ala-N-Me-Tyr(OCH₃)-Ala-N-Me-Gly-N-Me-Gly) 
• 112196-47-1 (12R,15S,18S,21S)-18-(4-Methoxy-benzyl)-12,15,17,21,23-pentamethyl-2-oxa-11,14,17,20,23-pentaaza-tricyclo[24.2.2.1^3,7]hentriaconta-1⁽²⁹⁾,3⁽³¹⁾,4,6,26⁽³⁰⁾,27-hexaene-10,13,16,19,22-pentaone 
• 112219-52-0 Boc-D-Ala-Ala-N-Me-Tyr(OMe)-Ala-N-Me-Gly-N-Me-Gly-OH 
• 112196-52-8 Boc-D-Ala-Ala-N-Me-Tyr(OMe)-N-Me-Gly-N-Me-Gly-OMe 
• 112196-81-3 BOC-D-Ala-L-Ala-NMe-L-Tyr(OMe)-L-Ala-OC₆F₅ 
• 112196-75-5 3-(3-{4-[2-({(S)-2-[(S)-2-{[(S)-2-((R)-2-tert-Butoxycarbonylamino-propionylamino)-propionyl]-methyl-amino}-3-(4-methoxy-phenyl)-propionylamino]-propionyl}-methyl-amino)-ethyl]-phenoxy}-phenyl)-propionic acid 

Relevant articles and documents

BOUVARDIN DERIVATIVES AND THERAPEUTIC USES THEREOF

The present invention is directed at bouvardin analogs arid related compounds for the treatment of disorders including cancer. Provided herein are bouvardin analogs and related compounds, pharmaceutical compositions and kits comprising at least one bouvar

Synthesis of [Tyr-5-Ψ(CH2NMe)-Tyr-6]RA-VII, a reduced peptide bond analogue of RA-VII, an antitumor bicyclic hexapeptide

A reduced peptide bond analogue of RA-VII, [Tyr-5-Ψ(CH 2NMe)-Tyr-6]RA-VII (3), was designed and synthesized. The key reduced cycloisodityrosine unit was prepared by reduction of the cycloisodityrosine derived from natural RA-VII, followed by co

SYNTHESIS OF CYCLO-N-METHYL-L-TYR-N-METHYL-L-TYR-D-ALA-L-ALA-O,N-DIMETHYL-L-TYR-L-ALA, A CYCLIC HEXAPEPTIDE RELATED TO THE ANTITUMOR AGENT DEOXYBOUVARDIN

A synthesis of the title cyclic hexapeptide is described.Its lack of antitumor activity shows that the 14-membered ring of deoxybouvardin is needed for activity.Efforts to oxidatively its phenolic groups failed to give deoxybouvardin.